Cara Therapeutics, Inc. (CARA) NASDAQ

5.32

-0.14(-2.56%)

Updated at April 15 04:00PM

Currency In USD

Valuation

Market Cap837.72M
Enterprise Value799.82M
P/E Ratio-4.12
PEG Ratio-0.2
Price/Sales Ratio1.14
Price/Book Ratio-63.52
Enterprise/Revenue-4.17
Enterprise/EBITDA0.48

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-9.93
Operating Margin-7.69

Management Effectiveness

Return On Assets-1.62
Return On Equity-7.56

Income Statement

Revenue7.14M
Revenue/Share0.13
Gross Profit7.14M
EBITDA-62.6M
Net Income-70.87M
Diluted EPS-1.55

Balance Sheet

Total Cash37.9M
Total Cash/Share0.69
Total Debt0
Total Debt/Equity0
Current Ratio11.03
Book Value Per Share-0.08

Price History

52-Week Change-79.11
52-Week High31.32
52-Week Low5.28
Moving Average 50 Days15.21
Moving Average 200 Days12.8

Statistics

Average Volume7,889
Shares Outstanding1.52M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:3
Last Split DateApril 16, 2025